Researchers in the U.K. analyzed vet records from over two million dogs to uncover the messy truth about canine diarrhea. Reading time 3 minutes Speaking from personal experience; fewer things in the ...
SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / January 2, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar”) today announced that it received notice from the U.S. Food and Drug Administration’s Center ...
CID confirmatory effectiveness trial expected to conclude in February 2026, ahead of FDA's June deadline - 51 dogs enrolled to date; ~49 more expected "Canalevia-CA1 is an important prescription drug ...
A novel non-antibiotic approach to diarrhea treatment is important because there are no FDA-approved drugs to treat general diarrhea in dogs, the second most common reason for visits to veterinary ...
Dogs undergoing chemotherapy are an important predictive model for the mechanism of action in humans experiencing diarrhea due to cancer treatment. Many cancer treatment agents provided to dogs are ...
Canalevia ® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for treatment of chemotherapy-induced diarrhea in dogs Jaguar is exploring the ...
SAN FRANCISCO, CA / ACCESS Newswire / December 10, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the U.S. Food and Drug Administration (FDA) has granted renewal of the conditional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results